Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

Hodgkin lymphoma

  • You have access
    Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease
    Regine Kluge, Tim Wittig, Thomas W. Georgi, Lars Kurch, Osama Sabri, W. Hamish Wallace, Tomasz Klekawka, Ana Fernández-Teijeiro, Francesco Ceppi, Jonas Karlén, Jane Pears, Michaela Cepelová, Alexander Fosså, Auke Beishuizen, Lisa Lyngsie Hjalgrim, Dieter Körholz, Christine Mauz-Körholz and Dirk Hasenclever
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 338-341; DOI: https://doi.org/10.2967/jnumed.120.247924
  • You have access
    18F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with 18F-FDG PET/CT as reference standard
    Martijn Vincent Verhagen, Leon J Menezes, Deena Neriman, Tom A Watson, Shonit Punwani, Stuart A Taylor, Ananth Shankar, Stephen Daw and Paul D Humphries
    Journal of Nuclear Medicine February 19, 2021, jnumed.120.260059; DOI: https://doi.org/10.2967/jnumed.120.260059
  • You have access
    Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab
    Aiping Chen, Fatima-Zohra Mokrane, Lawrence H. Schwartz, Franck Morschhauser, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Laetitia Vercellino, Olivier Casasnovas, Adrien Chauchet, Alain Delmer, Emmanuelle Nicolas-Virelizier, Hervé Ghesquières, Marie-Pierre Moles-Moreau, Anna Schmitt, Rémy Dulery, Krimo Bouabdallah, Cecile Borel, Mohamed Touati, Benedicte Deau-Fischer, Frédéric Peyrade, Romain-David Seban, Guillaume Manson, Philippe Armand, Roch Houot and Laurent Dercle
    Journal of Nuclear Medicine May 1, 2020, 61 (5) 649-654; DOI: https://doi.org/10.2967/jnumed.119.232827
  • You have access
    Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
    Jasmin Mettler, Horst Müller, Conrad-Amadeus Voltin, Christian Baues, Bernd Klaeser, Alden Moccia, Peter Borchmann, Andreas Engert, Georg Kuhnert, Alexander Drzezga, Markus Dietlein and Carsten Kobe
    Journal of Nuclear Medicine February 1, 2019, 60 (2) 207-211; DOI: https://doi.org/10.2967/jnumed.118.210047
  • You have access
    18F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?
    Thomas W. Georgi, Regine Kluge, Lars Kurch, Lidia Chavdarova, Dirk Hasenclever, Dietrich Stoevesandt, Tanja Pelz, Judith Landman-Parker, W. Hamish Wallace, Jonas Karlen, Ana Fernández-Teijeiro, Michaela Cepelova, Alexander Fosså, Walentyna Balwierz, Andishe Attarbaschi, Roland A. Ammann, Jane Pears, Andrea Hraskova, Anne Uyttebroeck, Auke Beishuizen, Karin Dieckmann, Thierry Leblanc, Stephen Daw, Julia Baumann, Dieter Körholz, Osama Sabri and Christine Mauz-Körholz
    Journal of Nuclear Medicine October 1, 2018, 59 (10) 1524-1530; DOI: https://doi.org/10.2967/jnumed.117.205633
  • You have access
    18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti–Programmed Death 1 Immune Checkpoint Inhibitor
    Laurent Dercle, Romain-David Seban, Julien Lazarovici, Lawrence H. Schwartz, Roch Houot, Samy Ammari, Alina Danu, Véronique Edeline, Aurélien Marabelle, Vincent Ribrag and Jean-Marie Michot
    Journal of Nuclear Medicine January 1, 2018, 59 (1) 15-24; DOI: https://doi.org/10.2967/jnumed.117.193011
  • You have access
    Interim 18F-FDG PET SUVmax Reduction Is Superior to Visual Analysis in Predicting Outcome Early in Hodgkin Lymphoma Patients
    Cédric Rossi, Salim Kanoun, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Olivier Humbert, Caroline Legouge, Marie Lorraine Chrétien, Jean-Noel Bastie, François Brunotte and René-Olivier Casasnovas
    Journal of Nuclear Medicine April 1, 2014, 55 (4) 569-573; DOI: https://doi.org/10.2967/jnumed.113.130609
  • You have access
    Interim 18F-FDG PET in Hodgkin Lymphoma: Would PET-Adapted Clinical Trials Lead to a Paradigm Shift?
    Lale Kostakoglu and Andrea Gallamini
    Journal of Nuclear Medicine July 1, 2013, 54 (7) 1082-1093; DOI: https://doi.org/10.2967/jnumed.113.120451
  • You have access
    International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
    Alberto Biggi, Andrea Gallamini, Stephane Chauvie, Martin Hutchings, Lale Kostakoglu, Michele Gregianin, Michel Meignan, Bogdan Malkowski, Michael S. Hofman and Sally F. Barrington
    Journal of Nuclear Medicine May 1, 2013, 54 (5) 683-690; DOI: https://doi.org/10.2967/jnumed.112.110890
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire